The Early Access to Medicines Scheme (EAMS) aims to make promising new medicines available to patients sooner. It was set up in 2015 and is run by the Medicines and Healthcare Products Regulatory Agency (MHRA).
Read about what the Early Access to Medicines Scheme (EAMS) is and how the EAMS makes decisions.
Find out about safety measures, drugs that are available and what to do if you want an EAMS drug.
Search our clinical trials database for all cancer trials and studies recruiting in the UK
Talk to other people affected by cancer
Questions about cancer? Call freephone or email us